Latest News about PFE
Recent news which mentions PFE
Tech Stocks Rise Ahead Of Key Earnings, Gold Smashes Records, Bitcoin Nears All-Time Highs: What's Driving Markets Tuesday?
October 29, 2024
From Benzinga
Nasdaq Surges Over 100 Points; Pfizer Earnings Top Views
October 29, 2024
From Benzinga
Pfizer Q3 Earnings: Revenue And Profit Beat On Heightened Demand For Paxlovid, Expects $10 Billion In 2024 Revenue From COVID Products
October 29, 2024
From Benzinga
From Benzinga
Dow Surges Over 250 Points Ahead Of Alphabet, Pfizer Earnings: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone
October 29, 2024
From Benzinga
Pfizer, Alphabet And 3 Stocks To Watch Heading Into Tuesday
October 29, 2024
From Benzinga
Global Psychedelic Drugs Market Expected To Reach $10.2B By 2028 Amid Growing Mental Health Crises
October 28, 2024
From Benzinga
These 7 Blunt Words Just Opened a Can of Worms For Pfizer's Stock
October 27, 2024
Tickers
PFE
From Motley Fool
3 Magnificent S&P 500 Dividend Stocks Down 43%, 20%, and 53% to Buy and Hold Forever
October 26, 2024
From Motley Fool
3 Spooky Signs That You're About to Lose Your Money on a Healthcare Stock Investment
October 26, 2024
From Motley Fool
Pfizer, Live Nation Entertainment And More On CNBC's 'Final Trades'
October 25, 2024
From Benzinga
Got $1,000? 2 Healthcare Stocks to Buy and Hold Forever.
October 25, 2024
From Motley Fool
3 Sweet Dividend Stocks to Treat Your Portfolio With This Halloween
October 25, 2024
From Motley Fool
Just After Pfizer's RSV Vaccine Approval For Younger Adults, GSK Layouts Encouraging Preliminary Data Showing Potential For Use In Larger Population
October 24, 2024
From Benzinga
CDC And Prevention Advisory Panel Backs Expanded Use Of Pfizer And Merck's Pneumococcal Vaccines
October 24, 2024
From Benzinga
5 High-Yield Dividend Stocks to Buy Without Hesitation
October 24, 2024
From Motley Fool
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
From Benzinga
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
October 23, 2024
From Benzinga
The Best Pharmaceutical Stock to Invest $1,000 in Right Now
October 23, 2024
Tickers
PFE
From Motley Fool
Activist Investor Starboard Slams Pfizer for Underperforming R&D And Overpaying for Acquisitions
October 22, 2024
From Benzinga
Viking Therapeutics Stock Up 240% YTD: Can Q3 Earnings, Weight-Loss Drug Drive Further Gains?
October 22, 2024
From Benzinga
Do Billionaires Israel Englander and Ken Griffin Know Something? Each Just Bought This Plagued Value Stock.
October 22, 2024
Tickers
PFE
From Motley Fool
From Motley Fool
3 Bargain Stocks to Buy in a Market That's Priced for Perfection
October 19, 2024
From Motley Fool
3 No-Brainer Pharmaceutical Stocks to Buy With $500 Right Now
October 18, 2024
From Motley Fool
From Benzinga
Guggenheim's Longstanding Pfizer Ties Tested Amid Starboard Battle
October 16, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.